Skip to main content
SpringerLink
Log in

Percutaneous transhepatic obliteration-related procedures for isolated gastric varices: experience of three cases

  • Case Report
  • Published:
Clinical Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Percutaneous transhepatic obliteration (PTO) can facilitate antegrade embolization of variceal veins. We herein report three patients who underwent percutaneous transhepatic sclerotherapy (PTS) or percutaneous transportal outflow-vessel-occluded sclerotherapy (PTOS) for isolated gastric varices. PTS was performed in Cases 1 and 2, and PTOS was performed in Case 3. Technical success was achieved in all patients without a decline in liver function; however, lack of a therapeutic benefit with rupture of esophageal varices occurred in Case 3. Case 3 had a history of pylorus gastrectomy plus Billroth-I reconstruction for gastric cancer and multiple feeding veins existed. PTO-related procedures are good treatment options for isolated gastric varices, but clinicians should be aware of the risk of treatment failure, especially the cases which have multiple feeding veins.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Palmer ED. On correlations between portal venous pressure and the size and extent of esophageal varices in portal cirrhosis. Ann Surg. 1953;138:741–4.

    Article  CAS  Google Scholar 

  2. Boregowda U, Umapathy C, Halim N, et al. Update on the management of gastrointestinal varices. World J Gastrointest Pharmacol Ther. 2019;10:1–21.

    Article  Google Scholar 

  3. Blei AT. TIPS and variceal bleeding. Ann Intern Med. 1992;117:266.

    Article  CAS  Google Scholar 

  4. McCormick PA, Dick R, Burroughs AK. Review article: the transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of portal hypertension. Aliment Pharmacol Ther. 1994;8:273–82.

    Article  CAS  Google Scholar 

  5. Spigos DG, Jonasson O, Mozes M, et al. Partial splenic embolization in the treatment of hypersplenism. AJR Am J Roentgenol. 1979;132:777–82.

    Article  CAS  Google Scholar 

  6. Kanagawa H, Mima S, Kouyama H, et al. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol. 1996;11:51–8.

    Article  CAS  Google Scholar 

  7. Hirota S, Matsumoto S, Tomita M, et al. Retrograde transvenous obliteration of gastric varices. Radiology. 1999;211:349–56.

    Article  CAS  Google Scholar 

  8. Lunderquist A, Vang J. Transhepatic catheterization and obliteration of the coronary vein in patients with portal hypertension and esophageal varices. N Engl J Med. 1974;291:646–9.

    Article  CAS  Google Scholar 

  9. Okuda K, Kimura K, Takayasu K. Percutaneous transhepatic portography and sclerotherapy. Semin Liver Dis. 1982;2:57–66.

    Article  CAS  Google Scholar 

  10. Yoshimatsu R, Yamagami T, Miura H, et al. Percutaneous transhepatic sclerotherapy with embolization of the drainage vein for a gastric varix. Acta Radiol Short Rep. 2014. https://doi.org/10.1177/2047981614530285.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Kawai N, Minaguchi H, Sato M, et al. Percutaneous transportal outflow-vessel-occluded sclerotherapy for gastric varices unmanageable by balloon-occluded retrograde transvenous obliteration. Hepatol Res. 2013;43:430–5.

    Article  Google Scholar 

  12. Kameda N, Higuchi K, Shiba M, et al. Management of gastric fundal varices without gastro-renal shunt in 15 patients. World J Gastroenterol. 2008;14:448–53.

    Article  Google Scholar 

  13. Scott J, Dick R, Long RG, et al. Percutaneous transhepatic obliteration of gastro-oesophageal varices. Lancet. 1976;2:53–5.

    Article  CAS  Google Scholar 

  14. Ninoi T, Nakamura K, Kaminou T, et al. TIPS versus transcatheter sclerotherapy for gastric varices. AJR Am J Roentgenol. 2004;183:369–76.

    Article  Google Scholar 

  15. Chikamori F, Kuniyoshi N, Kawashima T, et al. Percutaneous transhepatic obliteration for isolated gastric varices with gastropericardiac shunt: case report. Abdom Imaging. 2006;31:249–52.

    Article  CAS  Google Scholar 

  16. Kiyosue H, Matsumoto S, Yamada Y, et al. Transportal intravariceal sclerotherapy with N-butyl-2-cyanoacrylate for gastric varices. J Vasc Interv Radiol. 2004;15:505–9.

    Article  Google Scholar 

  17. Miyoshi H, Oshiba S, Matsumoto A, et al. Haptoglobin prevents renal dysfunction associated with intravariceal infusion of ethanolamine oleate. Am J Gastroenterol. 1991;86:1638–41.

    CAS  PubMed  Google Scholar 

  18. Sanyal AJ, Freedman AM, Luketic VA, et al. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology. 1997;112:889–98.

    Article  CAS  Google Scholar 

  19. Somberg KA. TIPS: safe, effective, better? Am J Gastroenterol. 1997;92:1412–6.

    CAS  PubMed  Google Scholar 

  20. Maeda H, Hirota S, Yamamoto S, et al. Radiologic variations in gastrorenal shunts and collateral veins from gastric varices in images obtained before balloon-occluded retrograde transvenous obliteration. Cardiovasc Intervent Radiol. 2007;30:410–4.

    Article  Google Scholar 

  21. Akahoshi T, Hashizume M, Tomikawa M, et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: a 10-year experience. J Gastroenterol Hepatol. 2008;23:1702–9.

    Article  Google Scholar 

  22. Koito K, Namieno T, Nagakawa T, et al. Balloonoccluded retrograde transvenous obliteration for gastric varices with gastrorenal or gastrocaval collaterals. AJR Am J Roentgenol. 1996;167:1317–20.

    Article  CAS  Google Scholar 

  23. Sonomura T, Sato M, Kishi K, et al. Balloon-occluded retrograde transvenous obliteration for gastric varices: a feasibility study. Cardiovasc Intervent Radiol. 1998;21:27–30.

    Article  CAS  Google Scholar 

  24. Fukuda T, Hirota S, Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol. 2001;12:327–36.

    Article  CAS  Google Scholar 

  25. Araki T, Hori M, Motosugi U, et al. Can balloon-occluded retrograde transvenous obliteration be performed for gastric varices without gastrorenal shunts? J Vasc Interv Radiol. 2010;21:663–70.

    Article  Google Scholar 

  26. Arai H, Abe T, Takagi H, et al. Efficacy of balloonoccluded retrograde transvenous obliteration, percutaneous transhepatic obliteration and combined techniques for the management of gastric fundal varices. World J Gastroenterol. 2006;12:3866–73.

    Article  Google Scholar 

  27. Wang J, Tian XG, Li Y, et al. Comparison of modified percutaneous transhepatic variceal embolization and endoscopic cyanoacrylate injection for gastric variceal rebleeding. World J Gastroenterol. 2013;19:706–14.

    Article  Google Scholar 

  28. Murata Y, Abe M, Furukawa S, et al. Clinical features of symptomatic primary biliary cirrhosis initially complicated with esophageal varices. J Gastroenterol. 2006;41:1220–6.

    Article  Google Scholar 

  29. Boku M, Sugimoto K, Nakamura T, et al. Percutaneous trans-hepatic obliteration for bleeding esophagojejunal varices after total gastrectomy and esophagojejunostomy. Cardiovasc Intervent Radiol. 2006;29:1152–5.

    Article  Google Scholar 

  30. Shinno N, Kawabata R, Furukawa H, et al. A case of esophagojejunal varices rupture after proximal gastrectomy with double-tract reconstruction. Surg Case Rep. 2020. https://doi.org/10.1186/s40792-020-0775-6.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Huang YH, Yeh HZ, Chen GH, et al. Endoscopic treatment of bleeding gastric varices by N-butyl-2-cyanoacrylate (Histoacryl) injection: long-term efficacy and safety. Gastrointest Endosc. 2000;52:160–7.

    Article  CAS  Google Scholar 

  32. Mishra SR, Sharma BC, Kumar A, et al. Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers: a randomized controlled trial. J Hepatol. 2011;54:1161–7.

    Article  CAS  Google Scholar 

  33. Garcia-Tsao G, Abraldes JG, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American association for the study of liver diseases. Hepatology. 2017;65:310–35.

    Article  Google Scholar 

  34. European Association for the Study of the Liver. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406–60.

    Article  Google Scholar 

  35. Shiba M, Higuchi K, Nakamura K, et al. Efficacy and safety of balloon-occluded endoscopic injection sclerotherapy as a prophylactic treatment for high-risk gastric fundal varices: a prospective, randomized, comparative clinical trial. Gastrointest Endosc. 2002;56:522–8.

    Article  Google Scholar 

  36. Ishikawa T, Imai M, Ko M, et al. Percutaneous transhepatic obliteration and percutaneous transhepatic sclerotherapy for intractable hepatic encephalopathy and gastric varices improves the hepatic function reserve. Biomed Rep. 2017;6:99–102.

    Article  Google Scholar 

  37. Uchiyama F, Murata S, Onozawa S, et al. Management of gastric varices unsuccessfully treated by balloon-occluded retrograde transvenous obliteration: long-term follow-up and outcomes. Sci World J. 2013. https://doi.org/10.1155/2013/498535.

    Article  Google Scholar 

  38. Kwak HS, Han YM. Percutaneous transportal sclerotherapy with N-butyl-2-cyanoacrylate for gastric varices: technique and clinical efficacy. Korean J Radiol. 2008;9:526–33.

    Article  Google Scholar 

Download references

Acknowledgements

We thank Angela Morben, DVM, ELS, from Edanz Group (https://en-author-services.edanzgroup.com/ac), for editing a draft of this manuscript.

Funding

None.

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan

    Suguru Hirose, Naoyuki Hasegawa, Masato Endo, Masahiko Terasaki, Kuniaki Fukuda, Yuji Mizokami & Kiichiro Tsuchiya

  2. Department of Radiology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan

    Kensaku Mori

  3. Department of Gastroenterology, National Hospital Organization Kasumigaura Medical Center, 2-7-14 Shimotakatsu, Tsuchiura, Ibaraki, 300-8585, Japan

    Kazunori Ishige & Kuniaki Fukuda

  4. Endoscopic Center, University of Tsukuba Hospital, 2-1-1 Amakubo, Tsukuba, Ibaraki, 305-8576, Japan

    Yuji Mizokami

Authors
  1. Suguru Hirose
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Naoyuki Hasegawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kensaku Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masato Endo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masahiko Terasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kazunori Ishige
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kuniaki Fukuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yuji Mizokami
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Kiichiro Tsuchiya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Naoyuki Hasegawa.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest for this article.

Ethical approval

The authors declare that this study conformed to the Declaration of Helsinki and was approved by the ethics committee of the University of Tsukuba (R02-236). This study does not contain identifying information of the patients. Informed consent was obtained from all patients in the form of opt-out on the web-site.

Human Rights

All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

Informed Consent

Informed consent was obtained from all patients in the form of opt-out on the web-site.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hirose, S., Hasegawa, N., Mori, K. et al. Percutaneous transhepatic obliteration-related procedures for isolated gastric varices: experience of three cases. Clin J Gastroenterol 15, 192–198 (2022). https://doi.org/10.1007/s12328-021-01548-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12328-021-01548-7

Keywords

Search

Navigation